secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001104659-23-086865
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedTech Acquisition adjourns special meeting on TriSalus merger to Aug 8; redemption deadline extended to Aug 4
--------------------------------------------------------------------------------

- Special meeting for TriSalus business combination adjourned to August 8, 2023 at 11:00 a.m. ET.
- Vote to adjourn: 7,134,393 for, 1,777 against; quorum of 96.5% voting power present.
- Redemption deadline for public stockholders extended to August 4, 2023 at 5:00 p.m. ET.
- Prior to meeting, MTAC filed 8-K regarding FDA written response for TriSalus' PERIO-01 clinical program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923086865/0001104659-23-086865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923086865/tm2322702d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-086865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer